Clinical calculator for Early mortality in Metastatic colorectal cancer: An analysis of Patients from 28 clinical trials in the aide et recherche en cancérologie digestive database

Journal of Clinical Oncology

Volumn 35, Issue 17, 2017, Pages 1929-1937

  Renfro, Lindsay A ^a   Goldberg, Richard M ^b   Grothey, Axel ^a   Sobrero, Alberto ^c   Adams, Richard ^e   Seymour, Matthew T ^f   Heinemann, Volker ^g   Schmoll, Hans Joachim ^h   Douillard, Jean Yves ^k   Hurwitz, Herbert ^o   Fuchs, Charles S ^p   Diaz Rubio, Eduardo ^q   Porschen, Rainer ⁱ   Tournigand, Christophe ^l,m   Chibaudel, Benoist ⁿ   Hoff, Paulo M ^r   Kabbinavar, Fairooz F ^s   Falcone, Alfredo ^d   Tebbutt, Niall C ^t   Punt, Cornelis J A ^u   Hecht, J Randolph ^s   Souglakos, John ^v   Bokemeyer, Carsten ^j   Cutsem, Eric Van ^w   Saltz, Leonard ^x   Gramont, Aimery de ⁿ   Sargent, Daniel J ^a   more..

^a Mayo Clinic   (Argentina)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g UNIVERSITY OF MUNICH   (Germany)

^h MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

ⁱ KLINIKUM BREMEN OST   (Germany)

^j UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^k CENTRE RENÉ GAUDUCHEAU   (France)

^l UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^m HENRI MONDOR HOSPITAL   (France)

ⁿ Franco British Institute   (France)

^o DUKE UNIVERSITY MEDICAL CENTER   (United States)

^p Department of Medical Oncology   (Argentina)

^q UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^r UNIVERSITY OF SÃO PAULO   (Brazil)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t AUSTIN HEALTH   (Australia)

^u UNIVERSITY OF AMSTERDAM   (Netherlands)

^v UNIVERSITY OF CRETE   (Greece)

^w UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^x MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; CANCER MORTALITY; CANCER PATIENT; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DATA BASE; HUMAN; METASTATIC COLORECTAL CANCER; NOMOGRAM; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; AGED; COLORECTAL TUMOR; DISEASE COURSE; FEMALE; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; REPRODUCIBILITY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; CLINICAL TRIALS, PHASE III AS TOPIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOMOGRAMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 85021775812     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.71.5771     Document Type: Article

References (17)

1. Denicoff AM, McCaskill-Stevens W, Grubbs SS, et al: The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and recommendations. J Oncol Pract 9: 267-276, 2013
2. Ploquin A, Olmos D, Ferté C, et al: Life-expectancy of patients enrolled in phase 1 clinical trials: A systematic review of published prognostic models. Crit Rev Oncol Hematol 83:242-248, 2012
3. McPhail S, Johnson S, Greenberg D, et al: Stage at diagnosis and early mortality from cancer in England. Br J Cancer 112:S108-S115, 2015 (suppl 1)
4. Downing A, Aravani A, Macleod U, et al: Early mortality from colorectal cancer in England: A retrospective observational study of the factors associated with death in the first year after diagnosis. Br J Cancer 108:681-685, 2013
5. Lieu CH, Renfro LA, de Gramont A, et al: Association of age with survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program. J Clin Oncol 32:2975-2984, 2014
6. Renfro LA, Loupakis F, Adams RA, et al: Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol 34:144-150, 2016
7. Shibutani M, Maeda K, Nagahara H, et al: The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer. BMC Cancer 15: 347, 2015
8. Köhne CH, Cunningham D, Di Costanzo F, et al: Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: Results of a multivariate analysis of 3825 patients. Ann Oncol 13:308-317, 2002
9. Chibaudel B, Bonnetain F, Tournigand C, et al: Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: A GERCOR study. Oncologist 16:1228-1238, 2011
10. Cheung WY, Renfro LA, Kerr D, et al: Determinants of early mortality among 37,568 patients with colon cancer who participated in 25 clinical trials from the Adjuvant Colon Cancer Endpoints Database. J Clin Oncol 34:1182-1189, 2016
11. Shi Q, de Gramont A, Grothey A, et al: Individual patient data analysis of progression-free survival versus overall survival as first-line end point for metastatic colorectal cancer in modern randomized trials: Findings from the Analysis and Research in Cancers of the Digestive System. J Clin Oncol 33: 22-28, 2015
12. Walsh SR, Cook EJ, Goulder F, et al: Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181-184, 2005
13. Proctor MJ, Morrison DS, Talwar D, et al: An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: A Glasgow Inflammation Outcome Study. Br J Cancer 104:726-734, 2011
14. Harrell F: Regression Modeling Strategies. New York, Springer-Verlag, 2010
15. Steyerberg E: Clinical Prediction Models. New York, Springer Science+Business Media, 2010
16. Loupakis F, Yang D, Yau L, et al: Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst 107:dju427, 2015
17. Venook AP, Niedzwiecki D, Innocenti F, et al: Impact of primary tumor location on overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance). J Clin Oncol 34, 2016 (suppl; abstr 3504)